Related Experiment Video
Updated: Dec 9, 2025

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
Published on: November 29, 2019
Serum Albumin Levels: Who Needs Them?
1University of Arizona, Tucson, AZ, USA.
Routine serum albumin testing in critically ill adults lacks strong evidence, except for specific illness scoring systems. Overuse can lead to unnecessary treatments and increased costs.
Area of Science:
- Critical Care Medicine
- Clinical Chemistry
Background:
- Serum albumin levels are frequently monitored in intensive care units (ICUs).
- Hypoalbuminemia (low serum albumin) is common in critically ill patients and associated with adverse outcomes.
- Albumin is an acute phase reactant, leading to fluctuating levels that correlate with illness severity.
Purpose of the Study:
- To review indications for ordering serum albumin levels in adult critically ill patients.
- To evaluate the supporting literature for these indications.
- To provide recommendations for appropriate serum albumin testing.
Main Methods:
- A critical narrative review was conducted.
- Searches included PubMed (1966-2020), Cochrane Library, and clinical practice guidelines.
- Bibliographies of retrieved articles were also searched.
Main Results:
- Common indications for ordering serum albumin include guiding albumin administration, estimating free drug levels (phenytoin, calcium), nutritional monitoring, and illness severity assessment.
- However, routine ordering of serum albumin levels is often not supported by robust evidence.
- Inappropriate testing can lead to unnecessary interventions and increased healthcare costs.
Conclusions:
- Except for use in specific severity-of-illness scoring systems, there is limited evidence to justify routine serum albumin level testing in critically ill patients.
- Clinicians should exercise caution when ordering serum albumin levels to avoid unnecessary treatments and costs.
More Related Videos
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Related Concept Videos
Serum Studies: Renal Function Tests
Nephrotic Syndrome I : Introduction
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Nephrotic Syndrome II : Assessment and Medical Management
Drug Distribution: Plasma Protein Binding
Chronic Kidney Disease II: Clinical Manifestations